U.S. Court of Appeals for the Federal Circuit, 2022

Novozymes North America, Inc. v. Danisco US Inc.

Novozymes North America, Inc. v. Danisco US Inc.
U.S. Court of Appeals for the Federal Circuit · Decided October 5, 2022

Novozymes North America, Inc. v. Danisco US Inc.

Opinion

Case: 21-2184 Document: 39 Page: 1 Filed: 10/05/2022

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ NOVOZYMES NORTH AMERICA, INC., Appellant v. DANISCO US INC., Appellee ______________________ 2021-2184 ______________________ Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2020- 00464. ______________________ JUDGMENT ______________________ JEFFREY PAUL KUSHAN, Sidley Austin LLP, Washing- ton, DC, argued for appellant. Also represented by LAUREN CRANFORD KATZEFF, JOSHUA JOHN FOUGERE; SONA DE, New York, NY.

PIER DEROO, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC, argued for appellee.

Also represented by MICHAEL J. FLIBBERT. ______________________ Case: 21-2184 Document: 39 Page: 2 Filed: 10/05/2022

THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (PROST, REYNA, and STOLL, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

October 5, 2022 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Case-law data current through December 31, 2025. Source: CourtListener bulk data.